ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for Arterys MICA; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09FDA-cleared profile
Arterys Inc. · CT/CTA; MRI · FDA-cleared (510(k))
Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.
Evidence takeaway. Evidence from the reviewed source record: Safety and performance were evaluated through software verification and validation against IEC 62304, ISO 14971, and FDA software and cybersecurity guidance. The packet reports hundreds of verification and validation tests, including mammography display-quality testing and comparison to Medis MR-CT VVA, but provides no numeric sensitivity, specificity, AUC, Dice, correlation, or reader-delta endpoint.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
This field has not been curated yet.
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Pre-existing DICOM or non-DICOM medical data, including CT or MR images uploaded from a PACS or scanner; Cardio AI supports 1.5T and 3.0T cardiovascular MR images, and Oncology AI processes MR or CT images.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-09 · FDA K192437: Arterys MICA
Source context, not route validation: The system has a Chrome desktop-browser client and Linux server, receives pre-existing images from a PACS or scanner, and manages DICOM and non-DICOM data, images, and patient information. The packet does not establish a specific local PACS, RIS, EHR, or interface version.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-09 · FDA K192437: Arterys MICA
Source context, not route validation: The exact FDA package describes Arterys MICA as client and server software, with the client designed to run on standard personal and business computers and usable in a Chrome desktop web browser, and the server software running on the Linux operating system. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The software has two components: i) client, and ii) server. The client software (i) can be used in a Chrome desktop web browser." … "The server software (ii) runs on the Linux operating system.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K192437: Arterys MICA
Source context, not route validation: Stored, processed, and transferred images and patient information; filtered and digitally manipulated images; quantitative cardiovascular data for blood flow and ventricular function; and oncology lesion presence, evaluation, quantification, follow-up, and documentation support.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-09 · FDA K192437: Arterys MICA
Unresolved route: Stored, processed, and transferred images and patient information; filtered and digitally manipulated images; quantitative cardiovascular data for blood flow and ventricular function; and oncology lesion presence, evaluation, quantification, follow-up, and documentation support.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-09 · FDA K192437: Arterys MICA
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Packet wording: "The software has two components: i) client, and ii) server. The client software (i) can be used in a Chrome desktop web browser." … "The server software (ii) runs on the Linux operating system.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Vendor statement. Entity bridge: arterys.com announces 'Arterys has joined Tempus... as Tempus Radiology'. The Tempus policy is an organizational vulnerability-handling statement; no certification or audit report was read, and exact-release scope is not established.
User qualification wording only; the summary specifies no training program or training offering for this device.
Vendor statement, not an attestation. The policy names Tempus generally and does not scope these commitments to any specific product release; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Arterys MICA; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for the exact K192437 configuration was established in this review.
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
8 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment
Scope: regulatoryIdentity, modalityContext
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: postmarketSafety
Scope: security
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Arterys Inc.
Authorized purpose: DICOM/non-DICOM image and data management with optional quantitative cardiac MR and oncology lesion evaluation, quantification, follow-up, and documentation support; the software does not directly generate a diagnosis or potential findings.
Circle Cardiovascular Imaging Inc.
Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Circle Cardiovascular Imaging Inc
Authorized purpose: Viewing, post-processing, qualitative and quantitative evaluation, cardiac measurements, calcium scoring, and evaluation of physician-identified vascular lesions in cardiovascular MR/CT images.
Arterys Inc.
Authorized purpose: Manages, views, processes, stores, transfers, filters, manipulates, and quantitatively measures DICOM and non-DICOM images and data, with optional Cardio AI and Oncology AI support.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history